British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...

Haleon's dividend grew 10% and is well-covered by FCF, but the 1.6% yield is less attractive compared to peers. See why I ...

UK's Haleon reported annual profit in line with market expectations on Thursday, as the Sensodyne toothpaste and Advil ...

Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five ...

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...

HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Sensodyne-maker Haleon’s annual profits rose in line with expectations last year as it got a boost in demand for its oral ...

Haleon po0sted a higher pretax profit for 2024 ... The maker of Panadol tablets, Sensodyne toothpaste and Centrum vitamins posted revenue of 11.23 billion pounds compared with 11.30 billion ...

Haleon has a 1-year low of $7.89 and a 1-year ... and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum ...

Haleon plc (NYSE: HLN) Q4 2024 Earnings Call Transcript February 27, 2025 Haleon plc misses on earnings expectations.

Haleon projects a gradual revenue and profit ... The company, which makes Sensodyne toothpaste, ENO antacids and Centrum multivitamins, projected organic revenue would grow between 4 per cent ...